PL377478A1 - Cykloalkenowe kwasy dikarboksylowe jako środki przeciwzapalne, immunomodulujące oraz antyproliferacyjne - Google Patents
Cykloalkenowe kwasy dikarboksylowe jako środki przeciwzapalne, immunomodulujące oraz antyproliferacyjneInfo
- Publication number
- PL377478A1 PL377478A1 PL377478A PL37747803A PL377478A1 PL 377478 A1 PL377478 A1 PL 377478A1 PL 377478 A PL377478 A PL 377478A PL 37747803 A PL37747803 A PL 37747803A PL 377478 A1 PL377478 A1 PL 377478A1
- Authority
- PL
- Poland
- Prior art keywords
- immunomodulatory
- inflammatory
- dicarboxylic acid
- acid compounds
- cycloalkene dicarboxylic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Virology (AREA)
- Otolaryngology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10260800 | 2002-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL377478A1 true PL377478A1 (pl) | 2006-02-06 |
Family
ID=32667540
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL377478A PL377478A1 (pl) | 2002-12-23 | 2003-12-17 | Cykloalkenowe kwasy dikarboksylowe jako środki przeciwzapalne, immunomodulujące oraz antyproliferacyjne |
PL377467A PL209303B1 (pl) | 2002-12-23 | 2003-12-17 | Związek aromatyczny, kompozycja farmaceutyczna zawierająca związek aromatyczny i zastosowanie związku aromatycznego jako środka przeciwzapalnego, immunomodulującego i antyproliferacyjnego |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL377467A PL209303B1 (pl) | 2002-12-23 | 2003-12-17 | Związek aromatyczny, kompozycja farmaceutyczna zawierająca związek aromatyczny i zastosowanie związku aromatycznego jako środka przeciwzapalnego, immunomodulującego i antyproliferacyjnego |
Country Status (22)
Country | Link |
---|---|
EP (3) | EP2283898A1 (pl) |
JP (3) | JP2006514023A (pl) |
KR (1) | KR101107456B1 (pl) |
CN (3) | CN1732163B (pl) |
AT (2) | ATE516284T1 (pl) |
AU (2) | AU2003293914B2 (pl) |
BR (2) | BR0317687A (pl) |
CA (2) | CA2509139C (pl) |
CY (1) | CY1111851T1 (pl) |
DE (1) | DE60330391D1 (pl) |
DK (1) | DK1578741T3 (pl) |
ES (1) | ES2368735T3 (pl) |
IL (2) | IL169184A (pl) |
MX (2) | MXPA05006889A (pl) |
NO (2) | NO20052907L (pl) |
NZ (1) | NZ541382A (pl) |
PL (2) | PL377478A1 (pl) |
PT (1) | PT1578741E (pl) |
RU (2) | RU2367650C2 (pl) |
SI (1) | SI1578741T1 (pl) |
WO (1) | WO2004056797A1 (pl) |
ZA (1) | ZA200504387B (pl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0921258A2 (pt) * | 2008-11-07 | 2018-10-23 | 4Sc Ag | terapia combinatória compreendendo inibidor de dhodh e metotrexato para o tratamento de doença autoimune |
TWI530286B (zh) * | 2009-05-04 | 2016-04-21 | 帕納特斯製藥格斯有限公司 | 作為抑制病毒化合物之抗發炎劑 |
US8686048B2 (en) | 2010-05-06 | 2014-04-01 | Rhizen Pharmaceuticals Sa | Immunomodulator and anti-inflammatory compounds |
US20140031383A1 (en) | 2011-02-08 | 2014-01-30 | Dana-Farber Cancer Institute, Inc. | Methods for treatment of melanoma |
RU2485112C1 (ru) * | 2012-04-26 | 2013-06-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Пермский государственный национальный исследовательский университет" | 4-(4-бромфенил)-4-оксо-2-{[3-(этоксикарбонил)-4,5-диметилтиен-2-ил]амино}-2-бутеновая кислота, обладающая противовоспалительной и анальгетической активностью |
RU2016144238A (ru) | 2014-04-11 | 2018-05-11 | Паноптес Фарма Гмбх | Противовоспалительные средства в качестве вирусостатических соединений |
SG11201608835VA (en) * | 2014-05-08 | 2016-11-29 | Panoptes Pharma Ges M B H | Compounds for treating ophthalmic diseases and disorders |
WO2018118947A1 (en) | 2016-12-21 | 2018-06-28 | Biotheryx, Inc. | Thienopyrrole derivatives for use in targeting proteins, compositions, methods, and uses thereof |
WO2022167402A1 (en) | 2021-02-02 | 2022-08-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of therapy comprising administering a therapeutically effective combination comprising a dhodh inhibitor and an idh inhibitor |
EP4320100A1 (en) | 2021-04-09 | 2024-02-14 | Immunic AG | Deuterated dhodh inhibitors |
TW202332433A (zh) | 2021-12-23 | 2023-08-16 | 德商埃慕尼克股份公司 | 含羧酸生物電子等排體之dhodh抑制劑 |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL186239B (nl) | 1975-06-05 | Hoechst Ag | Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze. | |
AU1526483A (en) * | 1982-06-14 | 1983-12-22 | Nippon Kayaku Kabushiki Kaisha | N-substituted-3,4,5,6-tetrahydrophthalamic acids |
ZA839187B (en) * | 1982-12-10 | 1984-07-25 | Ciba Geigy Ag | Amide compounds |
GB8311519D0 (en) * | 1983-04-27 | 1983-06-02 | Fisons Plc | Nitrogen heterocycles |
GB8323293D0 (en) * | 1983-08-31 | 1983-10-05 | Zyma Sa | Substituted flavene and thioflavene derivatives |
DE3402026A1 (de) | 1984-01-21 | 1985-07-25 | Basf Ag, 6700 Ludwigshafen | Neue 2-aminothiophenderivate |
DE3534440A1 (de) | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
DE3812225A1 (de) * | 1988-04-13 | 1989-10-26 | Basf Ag | Isoxazol(isothiazol)-5-carbonsaeureamide |
EP0418667B1 (de) * | 1989-09-22 | 1995-08-16 | BASF Aktiengesellschaft | Carbonsäureamide |
DE3932052A1 (de) * | 1989-09-26 | 1991-04-04 | Basf Ag | Oxazol- bzw. thiazolcarbonsaeureamide |
DE3933573A1 (de) * | 1989-10-07 | 1991-04-18 | Basf Ag | Carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide |
DE59106349D1 (de) | 1990-06-23 | 1995-10-05 | Basf Ag | Dicarbonsäureimide als Herbizide. |
DE4023048A1 (de) * | 1990-07-20 | 1992-01-23 | Basf Ag | Dicarbonsaeureimide, verfahren zu ihrer herstellung und ihre verwendung als herbizide |
DE4108181A1 (de) * | 1991-03-14 | 1992-09-17 | Basf Ag | Isoxazol- und isothiazol-5-carbonsaeureamide |
WO1993019720A2 (en) * | 1992-04-02 | 1993-10-14 | Smithkline Beecham Corporation | Compounds |
JP3055365B2 (ja) * | 1993-06-30 | 2000-06-26 | 東洋インキ製造株式会社 | 2,5−ジ(アリールアミノ)−3,6−ジヒドロテレフタル酸ジアルキルエステル類の製造法およびこれを中間体とするキナクリドン類の製造法 |
GB9320299D0 (en) | 1993-10-01 | 1993-11-17 | Roussel Lab Ltd | Isoxazole derivatives |
DE19547648A1 (de) | 1995-12-20 | 1997-06-26 | Hoechst Ag | Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate |
DE19610955A1 (de) | 1996-03-20 | 1997-09-25 | Hoechst Ag | Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid |
EP0924207A4 (en) * | 1996-08-27 | 2001-06-13 | Shionogi & Co | CHROMENE-3-CARBOXYLATE DERIVATIVES |
PL334250A1 (en) * | 1996-12-23 | 2000-02-14 | Du Pont Pharm Co | Nitrogen containing hetero-aromatic compounds and inhibitors of xa factor |
US6187797B1 (en) * | 1996-12-23 | 2001-02-13 | Dupont Pharmaceuticals Company | Phenyl-isoxazoles as factor XA Inhibitors |
US6020357A (en) * | 1996-12-23 | 2000-02-01 | Dupont Pharmaceuticals Company | Nitrogen containing heteroaromatics as factor Xa inhibitors |
DE69720773T2 (de) * | 1996-12-23 | 2004-01-29 | Bristol Myers Squibb Pharma Co | SAUERSTOFF ODER SCHWEFEL ENTHALTENDE 5-GLIEDRIGE HETEROAROMATISHE DERIVATIVE ALS FACTOR Xa HEMMER |
AU8150398A (en) * | 1997-06-19 | 1999-01-04 | Du Pont Pharmaceuticals Company | Inhibitors of factor xa with a neutral p1 specificity group |
US6339099B1 (en) * | 1997-06-20 | 2002-01-15 | Dupont Pharmaceuticals Company | Guanidine mimics as factor Xa inhibitors |
AU2108099A (en) | 1998-01-30 | 1999-08-16 | Procept, Inc. | Immunosuppressive agents |
GB9804343D0 (en) | 1998-02-27 | 1998-04-22 | Univ Cardiff | Chemical compounds |
AU1707700A (en) * | 1998-10-29 | 2000-05-22 | Bristol-Myers Squibb Company | Novel inhibitors of impdh enzyme |
JP4706810B2 (ja) * | 1999-06-24 | 2011-06-22 | 日本農薬株式会社 | ピリジン環ジカルボン酸ジアミド誘導体及び農園芸用殺虫剤並びにその使用方法 |
BR0011818A (pt) * | 1999-06-24 | 2002-03-19 | Nihon Nohyaku Co Ltd | Derivado de diamida do ácido dicarboxìlico heterocìclico,inseticida agrìcola e hortìcola e método papa aplicar um inseticida agrìcola e hortìcola |
WO2001021160A2 (en) * | 1999-09-23 | 2001-03-29 | Axxima Pharmaceuticals Aktiengesellschaft | Carboxymide and aniline derivatives as selective inhibitors of pathogens |
AU7622000A (en) | 1999-10-01 | 2001-05-10 | Institute Of Molecular And Cell Biology | Compounds for the treatment of viral-mediated diseases |
AU7961100A (en) * | 1999-10-28 | 2001-05-08 | Daiichi Pharmaceutical Co., Ltd. | Drug discharge pump inhibitors |
WO2001032628A1 (en) * | 1999-11-03 | 2001-05-10 | Bristol-Myers Squibb Pharma Company | Cyano compounds as factor xa inhibitors |
EP1296977A1 (en) * | 2000-06-23 | 2003-04-02 | Bristol-Myers Squibb Pharma Company | Heteroaryl-phenyl substituted factor xa inhibitors |
RU2181270C1 (ru) | 2000-07-21 | 2002-04-20 | Общество с ограниченной ответственностью "Медицинское предприятие "ХИТ плюс" | Способ повреждения термонетолерантных патологических биоструктур организма теплокровных |
JP2002128768A (ja) * | 2000-10-26 | 2002-05-09 | Dai Ichi Seiyaku Co Ltd | 薬剤排出ポンプ阻害作用を有する化合物 |
JP2002322054A (ja) * | 2001-04-26 | 2002-11-08 | Dai Ichi Seiyaku Co Ltd | 薬剤排出ポンプ阻害薬 |
EP2363396A1 (en) * | 2001-06-11 | 2011-09-07 | Virochem Pharma Inc. | Thiophene derivatives as antiviral agents for flavivirus infection |
MXPA04000224A (es) * | 2001-07-10 | 2005-07-25 | 4Sc Ag | Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos. |
DE10133665A1 (de) * | 2001-07-11 | 2003-01-30 | Boehringer Ingelheim Pharma | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung |
GB0219896D0 (en) * | 2002-08-27 | 2002-10-02 | Bayer Ag | Dihydropyridine derivatives |
JP4093023B2 (ja) * | 2002-11-15 | 2008-05-28 | コニカミノルタビジネステクノロジーズ株式会社 | 非磁性一成分現像用トナーおよび画像形成方法 |
-
2003
- 2003-12-17 JP JP2004561331A patent/JP2006514023A/ja active Pending
- 2003-12-17 AU AU2003293914A patent/AU2003293914B2/en not_active Ceased
- 2003-12-17 EP EP10185827A patent/EP2283898A1/en not_active Withdrawn
- 2003-12-17 CA CA2509139A patent/CA2509139C/en not_active Expired - Lifetime
- 2003-12-17 DE DE60330391T patent/DE60330391D1/de not_active Expired - Lifetime
- 2003-12-17 PL PL377478A patent/PL377478A1/pl not_active Application Discontinuation
- 2003-12-17 RU RU2005123402/04A patent/RU2367650C2/ru not_active IP Right Cessation
- 2003-12-17 RU RU2005123401/04A patent/RU2386625C2/ru active
- 2003-12-17 ES ES03789317T patent/ES2368735T3/es not_active Expired - Lifetime
- 2003-12-17 SI SI200332049T patent/SI1578741T1/sl unknown
- 2003-12-17 CN CN2003801073546A patent/CN1732163B/zh not_active Expired - Fee Related
- 2003-12-17 PL PL377467A patent/PL209303B1/pl unknown
- 2003-12-17 DK DK03789317.9T patent/DK1578741T3/da active
- 2003-12-17 NZ NZ541382A patent/NZ541382A/en not_active IP Right Cessation
- 2003-12-17 MX MXPA05006889A patent/MXPA05006889A/es active IP Right Grant
- 2003-12-17 MX MXPA05006890A patent/MXPA05006890A/es active IP Right Grant
- 2003-12-17 KR KR1020057011710A patent/KR101107456B1/ko active IP Right Grant
- 2003-12-17 EP EP03789317A patent/EP1578741B1/en not_active Expired - Lifetime
- 2003-12-17 AU AU2003299316A patent/AU2003299316A1/en not_active Abandoned
- 2003-12-17 PT PT03789317T patent/PT1578741E/pt unknown
- 2003-12-17 CA CA002509138A patent/CA2509138A1/en not_active Abandoned
- 2003-12-17 WO PCT/EP2003/014433 patent/WO2004056797A1/en active Application Filing
- 2003-12-17 EP EP03799487A patent/EP1581477B1/en not_active Expired - Lifetime
- 2003-12-17 CN CNA2006101397112A patent/CN1939896A/zh active Pending
- 2003-12-17 BR BR0317687-8A patent/BR0317687A/pt not_active Application Discontinuation
- 2003-12-17 CN CNA2003801073550A patent/CN1732147A/zh active Pending
- 2003-12-17 AT AT03789317T patent/ATE516284T1/de active
- 2003-12-17 BR BR0317731-9A patent/BR0317731A/pt not_active IP Right Cessation
- 2003-12-17 JP JP2004561332A patent/JP2006511564A/ja active Pending
- 2003-12-17 AT AT03799487T patent/ATE450498T1/de not_active IP Right Cessation
-
2005
- 2005-05-30 ZA ZA200504387A patent/ZA200504387B/en unknown
- 2005-06-15 IL IL169184A patent/IL169184A/en active IP Right Grant
- 2005-06-15 NO NO20052907A patent/NO20052907L/no not_active Application Discontinuation
- 2005-06-15 NO NO20052908A patent/NO335748B1/no not_active IP Right Cessation
- 2005-06-17 IL IL169257A patent/IL169257A/en not_active IP Right Cessation
-
2010
- 2010-06-03 JP JP2010127770A patent/JP5300789B2/ja not_active Expired - Fee Related
-
2011
- 2011-09-20 CY CY20111100906T patent/CY1111851T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL169257A0 (en) | Cycloalkene dicarboxylic acid compounds as anti-infammatory, immunomodulatory and anti-proliferatory agents | |
WO2001019776A3 (de) | Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften | |
DK1004578T3 (da) | 5-oxo-pyrrolidin-2-carboxylsyrehydroxamidderivater | |
IL159418A0 (en) | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | |
TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
DE50011582D1 (de) | Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften | |
AUPR213700A0 (en) | Antiviral agents | |
EE200100558A (et) | Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine | |
NO20014925L (no) | Farmasöytiske forbindelser | |
DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
CY1112057T1 (el) | Θεραπευτικος παραγων για διαταραχη επαρκειας τροφης στο στομαχι | |
HK1075894A1 (en) | Prucalopride-n-oxide | |
MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides | |
WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
DE69309029D1 (de) | Nonatetraensäurederivate | |
MXPA04002640A (es) | Esteres de analogos de 3-desoxi-vitamina d3. | |
WO2003063858A3 (fr) | Derives de l'acide haloacetamidobenzoique et leur utilisation pour le traitement de maladies parasitaires | |
ATE258934T1 (de) | Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe | |
UY26674A1 (es) | Derivados de pirrolidina y piperidina | |
CY1107067T1 (el) | Αλατα δικαρφοξυλικου οξεως της βεναζεπριλης και παρασκευη της βεναζεπριλης μεσω αυτων |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |